Related by context. All words. (Click for frequent words.) 71 transaminase elevations 71 moderate renal impairment 71 aminotransferases 70 aspartate aminotransferase AST 70 PASI scores 70 CIN3 70 alanine aminotransferase 70 hematologic toxicity 70 ALT elevations 70 neutrophil counts 69 leukopenia 69 alanine aminotransferase ALT 68 elevated ALT 68 Flu Cy 68 HBeAg seroconversion 68 antibody titer 68 HBeAg negative patients 68 EDSS scores 67 serum urate levels 67 Febrile neutropenia 67 intracranial hemorrhage ICH 67 mcg BID 67 relapsed MM 67 % CI #.#-#.# [007] 67 neurodevelopmental impairment 67 baseline HbA1c 67 lopinavir r arm 67 hepatitis C genotype 67 clinically meaningful improvement 67 lymphopenia 67 hematopoietic cancers 67 CR nPR 67 SGPT 67 thromboembolic events 67 ALT flares 67 PSA nadir 66 macroalbuminuria 66 beta blocker therapy 66 oxycodone CR 66 extrapyramidal symptoms 66 ALT elevation 66 elevated serum creatinine 66 serum phosphate 66 AST ALT 66 FluCAM arm 66 aspartate aminotransferase 66 BARACLUDE ® 66 EDSS score 66 serum creatinine levels 66 Serum creatinine 66 severe neutropenia 66 virologic failure 66 serum HBV DNA 66 ertapenem 66 leucopenia 66 tipranavir r 66 morphometric vertebral fractures 66 APTIVUS r 66 severe exacerbations 66 carotid stenosis 66 primary aldosteronism 66 hepatorenal syndrome 66 mcg albinterferon alfa 2b 66 lamivudine refractory patients 66 liver histology 66 mg BID dose 66 NNRTI resistance 66 recurrent VTE 66 recurrent venous thromboembolism 66 glycated hemoglobin levels 66 #mmHg [001] 66 TMP SMX 66 receiving VICTRELIS 66 plus methotrexate 66 intravascular hemolysis 66 hypophosphatemia 66 pmol L 66 MADRS score 66 rFVIIa 66 BENICAR HCT 66 adjunctive placebo 65 β blockers 65 μmol L 65 HBeAg 65 elevated creatinine 65 plasma leptin 65 acromegalic patients 65 REYATAZ r arm 65 mIU L 65 serum homocysteine 65 preoperative PSA 65 octreotide LAR 65 ng dL 65 cranial irradiation 65 complete cytogenetic response 65 methotrexate monotherapy 65 corticosteroid therapy 65 histological subtype 65 proliferative diabetic retinopathy 65 urate lowering therapy 65 depressive symptomatology 65 baseline serum creatinine 65 corticosteroid dose 65 adjunctive ABILIFY 65 aminotransferase ALT 65 NYHA functional class 65 Hb A1C 65 % CI #.#-#.# [003] 65 lymphocytosis 65 cabazitaxel 65 myeloperoxidase 65 serum aminotransferase levels 65 CMV infection 65 PRADAXA #mg 65 ovarian carcinoma 65 receiving ISENTRESS 65 troponin T 65 isolated systolic hypertension 65 #OHD 65 pCR 65 virological response 65 Thrombocytopenia 65 virological failure 65 NNT = 65 atherogenic dyslipidemia 65 leukocytosis 65 TEAEs 65 severe rotavirus gastroenteritis 65 experienced virologic failure 65 genotypic resistance 65 leukocyte count 65 overt nephropathy 65 CCyR 65 de novo AML 65 evaluable subjects 65 grade cervical intraepithelial 65 albumin excretion rate 65 CP CPPS 65 placebo dexamethasone 65 HBeAg negative 64 Hypotension 64 salmeterol fluticasone 64 CrCl 64 symptomatic aortic stenosis 64 mg ustekinumab 64 EXJADE 64 â ‰ ¥ 64 metastatic GIST 64 chlorambucil 64 serum testosterone 64 elevated troponin 64 serum cortisol 64 pyridostigmine 64 HbA 1c levels 64 Ishak fibrosis score 64 QTcF 64 mcg kg REBETOL 64 μg L 64 serum urate 64 mmHg diastolic 64 serum LDL cholesterol 64 elevated LDH 64 caspofungin 64 mycophenolate mofetil 64 NIHSS 64 blood phenylalanine Phe 64 umol L 64 paricalcitol 64 VaD 64 hemoglobin Hb 64 pg mL 64 HIV HCV coinfected 64 pg ml 64 LV dysfunction 64 SCIg 64 transaminases 64 CIN2 + 64 hypercholesterolaemia 64 aldosterone antagonist 64 virologic response 64 mg Proellex 64 CCR5 tropic HIV 64 fasting triglyceride levels 64 MCyR 64 log# reduction 64 p ≤ 64 paraprotein 64 PREZISTA r arm 64 fluticasone salmeterol 64 nephrotoxicity 64 elevated transaminases 64 recurrent ischemia 64 % Confidence Interval 64 glomerular filtration 64 serum folate 64 serum IGF 64 serum parathyroid hormone 64 serum lipid levels 64 cytopenias 64 HbA1C levels 64 mg/m2 dose 64 inflammatory acne 64 thrombocytopenic 64 urine albumin 64 sulfasalazine 64 blood Phe levels 64 chronic periodontitis 64 lactate dehydrogenase LDH 64 polyp recurrence 64 moderate hepatic impairment 64 PREZISTA ritonavir 64 colorectal adenoma 64 dapagliflozin plus 64 postoperative complication 64 Toxicities 64 nonvertebral fracture 64 arterial thromboembolic events 64 biologic DMARD 64 pulmonary capillary wedge 63 abdominal adiposity 63 mucosal inflammation 63 affective psychosis 63 androgen deprivation 63 transferrin saturation 63 thromboembolic 63 lumbar spine BMD 63 mild renal insufficiency 63 elevated triglyceride levels 63 neurologic symptoms 63 leukemia AML 63 mm Hg systolic 63 salmeterol fluticasone propionate 63 comparator arm 63 undetectable viral 63 seroprotection 63 mcg QD 63 recurrent glioblastoma multiforme 63 serum potassium 63 NIH CPSI 63 osteoporotic vertebral compression fractures 63 mmol l 63 venlafaxine XR 63 hypoperfusion 63 hsCRP levels 63 hepatic enzymes 63 FluCAM 63 overt hypothyroidism 63 severe renal impairment 63 x ULN 63 achieved ACR# 63 Non inferiority 63 pulmonary exacerbation 63 4mg/kg 63 baseline FEV 63 serum ALT 63 mg kg dose 63 primary IGFD 63 fluvastatin 63 hyperphenylalaninemia HPA due 63 Retreatment 63 OSAHS 63 Kinoid 63 trimethoprim sulfamethoxazole 63 TNF antagonist 63 5-FU/LV 63 mL/min/#.# m 2 63 anagrelide 63 p = .# [002] 63 T2DM 63 serum HCV RNA 63 asthma exacerbation 63 steroid dexamethasone 63 #mg dose [002] 63 nondiabetic patients 63 clodronate 63 CK MB 63 doxorubicin docetaxel 63 bezafibrate 63 gestational hypertension 63 indinavir 63 nonsevere 63 CHOP chemotherapy 63 Stent thrombosis 63 Doxil ® 63 transaminase levels 63 SRBD 63 spirometric 63 creatine kinase 63 PHPT 63 maximal doses 63 HER2 expression 63 pT3 63 cirrhotic patients 63 symptomatic VTE 63 unfavorable cytogenetics 63 haematologic 63 ecchymosis 63 folinic acid 63 bronchial hyperresponsiveness 63 prostate carcinoma 63 HIV RNA 63 HER2 overexpression 63 HBeAg positive 63 Severe Primary IGFD 63 CsA 63 splenectomized patients 63 serum estradiol 63 argatroban 63 lymphocyte counts 63 cisplatin chemotherapy 63 pulmonary toxicity 63 #.#/#.# mm Hg [003] 63 myalgia arthralgia 63 nonpregnant women 63 platelet reactivity 63 chronic GVHD 63 benazepril 63 clinically meaningful reductions 63 tapentadol IR 63 perioperatively 63 ADPKD 63 recurrent UTI 63 GH deficiency 63 #.#mg/dL 63 ximelagatran 63 ergocalciferol 63 abacavir Ziagen 63 serum ferritin 63 CIMZIA TM 63 neutropenic patients 63 amoxicillin clavulanate 63 serum retinol 63 nadolol 63 inotropic 63 intact parathyroid hormone 63 definite stent thrombosis 63 induce orthostatic hypotension 63 serum phosphate levels 63 serum antibody 63 #mg/day [001] 63 Renal dysfunction 63 micafungin 63 antibody titers 63 coronary stenosis 63 HAM D# scores 63 receiving golimumab 63 IGFD 63 serum IgG 63 PaO 2 63 plasma folate 63 thrombocytosis 63 p = NS 63 DOXIL 63 malignant neoplasm 63 seropositivity 62 abacavir lamivudine 62 neutropaenia 62 Pred Forte 62 log# copies mL 62 adriamycin 62 #OHD levels 62 airway hyper responsiveness 62 virologic breakthrough 62 hypoglycemic events 62 dose atorvastatin 62 reactogenicity 62 blood Phe 62 decompensated heart failure 62 8mg/kg 62 RLAI 62 LVNC 62 neurologic deficits 62 metformin monotherapy 62 dermatologic toxicities 62 subclinical hypothyroidism 62 TT genotype 62 aminotransferase levels 62 PsA 62 prolonged QT interval 62 iPTH 62 mg BID 62 deletion 5q 62 moderately emetogenic 62 hyperkalemia 62 seropositive patients 62 tipranavir ritonavir 62 CC genotype 62 Angioedema 62 neoplasias 62 follicular lymphomas 62 Tumor shrinkage 62 bortezomib refractory 62 sUA 62 DAS# remission 62 intraventricular hemorrhage 62 del 5q MDS 62 systemic corticosteroid 62 gm dl 62 NPH insulin 62 ULORIC 62 mm ³ 62 pentoxifylline 62 SGOT 62 oxycodone IR 62 adefovir 62 rhGH 62 bronchopulmonary dysplasia 62 sustained virological response 62 hyperoxaluria 62 lamotrigine 62 thyrotropin 62 receiving XGEVA 62 salmeterol HFA MDI 62 QTc 62 virologic responses 62 saline placebo 62 #q# deletion syndrome 62 posaconazole 62 neutrophil count 62 MMSE scores 62 dysuria 62 T2 lesions 62 ACR# responses 62 CIMZIA ™ 62 hydroxyvitamin D levels 62 Infusion Reactions Severe 62 hemoglobin A1c levels 62 colorectal carcinoma 62 Aspergillus infections 62 malarial anemia 62 intravenous bisphosphonates 62 pegIFN 62 baseline LDH 62 serum IgE 62 dopaminergic therapy 62 serum phosphorous 62 nonmelanoma skin cancers 62 intravenous vancomycin 62 DAS# CRP 62 atrophic gastritis 62 Adjuvant chemotherapy 62 Asymptomatic 62 mEq L 62 highly emetogenic 62 histologic subtype 62 mutated KRAS 62 NSTEMI 62 mCRC acneform rash 62 aldosterone antagonists 62 NATRECOR R 62 serologically active patients 62 pimecrolimus cream 62 ALT normalization 62 isoproterenol 62 microg 62 neurologic impairment 62 thrombotic complications 62 peginterferon alfa 62 HIV uninfected 62 Primary IGFD 62 retinal vein occlusion 62 eosinophil count 62 HbF 62 FOLFOX4 62 P = .# 62 PREZISTA r 62 anemia neutropenia 62 clinically meaningful improvements 62 divalproex sodium 62 hematologic abnormalities 62 hypertensives 62 achieved CCyR 62 CIN2 62 FOLPI 62 proliferative retinopathy 62 neutropenic fever 62 titrated glipizide 62 SCr 62 HBeAg positive patients 62 urothelial carcinoma 62 Crohn Disease Activity 62 conventional DMARDs 62 Fluid retention 62 #.#mmol L [002] 62 IDDM 62 ACR# response 62 HeFH 62 autoantibody positive 62 #mg BID [001] 62 somatostatin analog 62 graft dysfunction 62 heterozygotes 62 renal impairment 62 systemic corticosteroids 62 sensory neuropathy 62 MMSE score 62 QTc prolongation 62 PCNSL 62 Decitabine 62 FDG uptake 62 peg interferon 62 concomitant medications 62 candidemia 62 generalized edema 62 nicardipine 62 unstable angina pectoris 62 fasting plasma glucose FPG 62 mRS 62 ACTEMRA TM 62 tirofiban 62 osteopenic 62 ‰ ¥ 62 Neutropenia 62 nmol 62 lactate dehydrogenase 62 KRAS mutant tumors 62 sotalol 62 statistical significance p 62 CANCIDAS 62 gross hematuria 62 hypoglycemic episodes 62 antimicrobial prophylaxis 62 angioneurotic edema 62 folate concentrations 62 affective psychoses 62 mg eq 62 HbA 1c 62 mRCC 62 pulmonary exacerbations 62 bioavailable testosterone 62 ASCUS 62 prednisone prednisolone 62 certolizumab 62 hypoxemia 62 myelosuppression 62 preintervention 62 TDF FTC 61 triiodothyronine 61 biochemical relapse 61 RBC transfusions 61 pegylated IFN 61 β blocker 61 nmol liter 61 liposomal amphotericin B 61 ritonavir boosted 61 poor metabolizers 61 tolvaptan 61 HNSCC 61 ARCALYST ® 61 febrile neutropenia 61 chloride secretion 61 sitosterol 61 azacitidine 61 hyperammonemia 61 ara C 61 EBV infection 61 HBV infections 61 Known hypersensitivity 61 #.#ng/ml 61 hypoglycaemic episodes 61 Engerix B 61 chlamydial infection 61 lichen planus 61 bacteriuria 61 #mg/day [002] 61 lipid elevations 61 mIU ml 61 gastric adenocarcinoma 61 platelet inhibition 61 nmol L. 61 Subgroup analysis 61 hypercalcemia 61 mcg dL 61 CIN3 + 61 gadobutrol 61 SGRQ 61 triacylglycerol concentrations 61 endometrial hyperplasia 61 invasive candidiasis 61 nonischemic 61 ejection fractions 61 normal ULN 61 perioperative mortality 61 glycated hemoglobin HbA1c 61 hemorrhagic cystitis 61 viraemia 61 viral titers 61 antiretroviral naive 61 systolic dysfunction 61 RESIST studies 61 PAOD 61 ECOG PS 61 % CI #.#-#.# [004] 61 median survivals 61 hyperalgesia 61 mmHg systolic 61 nonsignificant difference 61 advanced adenoma 61 HER2 positive cancers 61 Acute Myeloid Leukaemia AML 61 plasma creatinine 61 nonmetastatic prostate cancer 61 severe periodontitis 61 virologic suppression 61 INVEGA ® 61 tryptase 61 adrenalectomy 61 renal insufficiency 61 serum PSA 61 TMC# r 61 μg dL 61 CDAI score 61 intratumoral 61 CD4 + cell 61 extrapyramidal symptoms EPS 61 splenectomized 61 chronic renal insufficiency 61 diabetes mellitus DM 61 malabsorptive 61 serum magnesium 61 acetabular dysplasia 61 mcg dose 61 serum sodium 61 corrected QT interval 61 GOUT 61 serum triglycerides 61 atheroma volume 61 histologically proven 61 fasting triglycerides 61 serum transaminases 61 coagulopathy 61 anterior uveitis 61 recurrent genital herpes 61 atorvastatin #mg 61 viremia 61 serum vitamin D 61 LVEF 61 euthymic patients 61 obstructive CAD 61 laboratory abnormalities 61 antiretroviral naïve 61 REMICADE monotherapy 61 Insulin sensitivity 61 sinus bradycardia 61 hypokalemia 61 NYHA Class II 61 abnormal cytology 61 dermatologic reactions 61 glycosylated hemoglobin HbA1c 61 p = #.# [003] 61 HCV genotype 61 NAbs 61 non squamous NSCLC 61 microvascular complications 61 inhaled budesonide 61 metastatic lung cancer 61 XIENCE V PROMUS Stent 61 invasive aspergillosis 61 antiandrogens 61 onset diabetes mellitus 61 intravesical therapy 61 specific antigen PSA 61 hematologic parameters 61 IPAH 61 ventricular tachyarrhythmia 61 efalizumab 61 μg mL 61 dalteparin 61 liver transaminases 61 PEG IFN 61 noncardiac 61 sustained virologic response 61 multivariable adjusted 61 LTBI 61 reflux symptoms 61 CIMZIA TM certolizumab pegol 61 piperacillin tazobactam 61 tuberculin skin testing 61 enteroviral infection 61 HGPIN 61 mcL 61 receiving immunosuppressive therapy 61 antithrombotic therapy 61 hip BMD 61 bladder carcinoma 61 lymphocyte count 61 posttreatment 61 reduce serum phosphate 61 CR CRu 61 HPA axis suppression 61 #.#/#.# mmHg [001] 61 hemoglobin A1c HbA1c 61 antioxidant supplementation 61 Zometa hazard 61 MULTAQ 61 aminotransferase elevations greater 61 bacterial prostatitis 61 GnRH agonist 61 tolterodine ER 61 creatine kinase CK 61 HPV-#/# 61 neovascular 61 orchitis 61 cerebrovascular events 61 pancreatic adenocarcinoma 61 undetectable HBV DNA 61 Fasting blood glucose 61 hemoptysis 61 dose cytarabine 61 Index CDAI 61 mcg mL 61 Noxafil 61 unresectable HCC 61 Scale EDSS score 61 CI -#.# 61 microbiological eradication 61 vaccinees 61 hemorrhagic complications 61 -#.# mg dL [002] 61 ß blockers 61 pelvic irradiation 61 timepoints 61 aged ≥ 61 GSTT1 61 nonvertebral fractures 61 serum selenium 61 macrolide antibiotic 61 plasma homocysteine 61 Severe hypoglycemia 61 ruboxistaurin 61 Postoperative complications 61 Arch Intern Med 61 Thal Dex 61 hematologic adverse 61 dyspareunia 61 hematological parameters 61 precancerous cervical lesions 61 echocardiographic parameters 61 RSV infections 61 pegaptanib 61 hypogonadal 61 cardiac dysfunction 61 locoregional disease 61 S. aureus infection 61 peginterferon alfa 2a 61 juvenile idiopathic arthritis JIA 61 abnormal lipid 61 Follicular Lymphoma 61 gonococcal infections 61 serum leptin 61 NMIBC 61 cytomegalovirus infection 61 KRAS mutations occur 61 dopamine partial agonist 61 Hepatotoxicity 61 thromboembolism 61 Serious adverse reactions 61 PegIFN RBV 61 fetal malformations 61 haematological toxicity 61 mm Hg diastolic 61 renal cell carcinomas 61 eplerenone 61 OAB symptoms 61 statin monotherapy 61 basiliximab 61 Exacerbation 61 median CD4 61 T1DM 61 attain statistical significance 60 uM 60 severe hypersensitivity reactions 60 serum PTH 60 creatine phosphokinase 60 heterozygous FH 60 B7 H3 60 baseline A1C 60 heavily pretreated 60 hemagglutination inhibition 60 thiazide 60 stage IIIB 60 hematological toxicity 60 μg liter 60 acarbose 60 overactive bladder symptoms 60 akinesia 60 IGFBP 3 60 Pegylated Liposomal Doxorubicin 60 apolipoprotein B 60 nmol l 60 rimonabant #mg 60 ABCB1 60 solifenacin 60 autonomic dysfunction 60 thromboembolic complications 60 rapid virological response 60 adalimumab 60 del 5q 60 IgG antibody 60 intima media thickness 60 adverse cytogenetics 60 hyperprolactinemia 60 Atypical Hemolytic Uremic Syndrome 60 LPV r 60 isoprostane 60 chemoradiotherapy 60 delayed CINV 60 daunorubicin 60 Pegylated Interferon 60 postoperative AF 60 lowest tertile 60 knee osteoarthritis OA 60 Ribavirin causes 60 IV bisphosphonates 60 elevated uric acid 60 REYATAZ ritonavir 60 Prehypertension 60 monoinfected patients 60 CMV disease 60 BMPR2 60 HAQ DI 60 % CI #.#-#.# [008] 60 Eur J Endocrinol 60 neurologic dysfunction 60 salivary flow 60 FOLFIRINOX 60 ALVESCO 60 adenoma recurrence 60 aldosterone antagonist therapy 60 CK # plasma concentrations 60 placebo p = 60 SPRYCEL ® 60 receiving Vectibix monotherapy 60 B Cell Lymphoma 60 hours postdose 60 rizatriptan 60 PSADT 60 Nebulized 60 gastric carcinoma 60 Vitamin B# deficiency 60 ARIXTRA 60 eosinophilic asthma 60 adrenal insufficiency 60 FOLFIRI alone 60 elevated LDL cholesterol 60 fosamprenavir 60 hyperbilirubinemia 60 metastatic neuroendocrine tumors 60 moderate atopic dermatitis 60 mitoxantrone plus 60 FDA defined valvulopathy 60 bisoprolol 60 mL kg 60 inhibin 60 microvessel density 60 Diffuse Large B 60 -#.# log# 60 chemoradiation therapy 60 SSc 60 oxcarbazepine 60 S. aureus colonization 60 posttransplant 60 triglyceride TG 60 hepatic fibrosis 60 HOMA IR 60 mL/min/#.# m2 60 Heavy menstrual bleeding 60 rhTSH 60 g dl 60 follicular lymphoma FL 60 EpCAM expression 60 HSCT 60 silent ischemia 60 deep venous thromboses 60 intravenous diuretics 60 thyrotropin levels 60 perioperative complications 60 cTnT 60 immunoreactivity 60 esophagitis 60 paroxysmal AF 60 ATACAND 60 imiquimod cream 60 non hematological toxicities 60 hepatotoxicity 60 acetaminophen codeine 60 dexrazoxane 60 adalimumab Humira 60 μg ml 60 cerebral vasospasm 60 urine NGAL 60 Haptoglobin 60 Nonspecific 60 plasma uric acid 60 receptor blocker 60 osteosarcomas 60 hyperhomocysteinemia 60 thyrotoxicosis 60 azoospermia 60 serum prostate 60 dyslipidaemia 60 Platelet counts 60 vaccine serotypes 60 calculated creatinine clearance 60 FFNS 60 elevated homocysteine 60 hypovitaminosis D 60 UGT#A# * 60 lispro 60 teriflunomide 60 atherothrombotic events 60 receiving highly emetogenic 60 Peg IFN 60 nmol L 60 % CI #.#-#.# [006] 60 MGd 60 alfuzosin 60 prostate cancer CaP 60 pamidronate 60 prospectively stratified 60 pulmonary dysfunction 60 elevated bilirubin 60 oxygen desaturation 60 plasma pharmacokinetics 60 LHRH agonists 60 COPD exacerbation 60 metoprolol tartrate 60 mg TID 60 preoperative chemotherapy 60 Peginterferon 60 homocysteine concentrations 60 #μg [001] 60 angiotensin converting enzyme inhibitors 60 nonalcoholic steatohepatitis 60 bFGF 60 oral antidiabetic drugs 60 haloperidol Haldol 60 tamsulosin 60 thyroglobulin 60 elevated IOP 60 mCi 60 nitroprusside 60 Myelosuppression 60 HbA1C 60 histologically confirmed 60 intestinal metaplasia 60 neurological sequelae 60 binary restenosis 60 LNG IUS 60 periprocedural 60 tapentadol ER 60 oral prednisolone 60 MIC# [001] 60 DAS# scores 60 antiepileptic drugs AEDs 60 serum calcium 60 flutamide 60 pegylated interferon alfa 2b 60 peripheral sensory neuropathy 60 trastuzumab Herceptin ® 60 fasting glucose levels 60 Psoriasis Area 60 subsyndromal 60 vasopressor 60 TIMP 1 60 dysthymia 60 QT interval prolongation 60 cutaneous manifestations 60 serum uric acid 60 low expressors 60 radiographic progression 60 canakinumab 60 infliximab monotherapy 60 glulisine 60 detrusor overactivity 60 hypofractionated radiation 60 IOP lowering 60 symptomatic intracranial hemorrhage 60 Myelodysplastic Syndrome MDS 60 rheumatoid factor 60 cinacalcet 60 mCRC patients 60 griseofulvin 60 Aortic stenosis 60 neutropenia dehydration dyspnea 60 Apolipoprotein B 60 coronary calcification 60 cholangiocarcinoma 60 renal toxicity 60 lymphocytic leukemia 60 artery stenosis 60 biochemical recurrence 60 INFERGEN 60 pulmonary arterial 60 HRCT 60 Juvenile Idiopathic Arthritis 60 angina chest 60 non splenectomized 60 femoral neck BMD